View Author
dai: 297290517
scopus: 9275974500

Bannink, E.M.N.

(Ellen Bannink)


igf-i gh treatment growth height treatment level children group gh therapy study turner syndrome turner syndrome therapy adult women effect hormone patient igf-i levels adult height chapter igfbp growth hormone treatment serum endocrinol estrogen binnenwerk _banink 20-8-2006 sga children insulin metab aortic growth hormone hrqol puberty result development difference factor ts women gh-treated baseline value dosage ratio population month stature control trial blood muinck keizer-schrama sm change pressure height sds range pubertal discontinuation disease measurement insulin sensitivity follow-up blood pressure reference glucose gh dose estrogen therapy questionnaire igf-i sds igfbp -3 breast function gh discontinuation quality aorta evaluation response model




9 Most Recent Publications

Adult height and health-related quality of life after growth hormone therapy in small for gestational age subjects (Article)
Bannink, E.M.N. Djurhuus, C.B. Christensen, T. Jøns, K. Hokken-Koelega, A.C.S.
2010-06-01
Long-Term follow-up of GH-treated girls with turner syndrome: BMI, blood pressure, body proportions (Article)
Bannink, E.M.N. Palen, R.L.F. van der Mulder, P.G.H. Muinck Keizer-Schrama, S.M.P.F. de
2009-06-01
Long-Term follow-up of GH-treated girls with turner syndrome: Metabolic consequences (Article)
Bannink, E.M.N. Palen, R.L.F. van der Mulder, P.G.H. Muinck Keizer-Schrama, S.M.P.F. de
2009-06-01
Puberty induction in Turner syndrome: Results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels (Article)
Bannink, E.M.N. Sassen, C. van Buuren, S. van Jong, F.H. de Leguin, M. Mulder, P.G.H. Muinck Keizer-Schrama, S.M.P.F. de
2009-02-01
Cardiac status after childhood growth hormone treatment of Turner syndrome (Article)
Berg, J. van den Bannink, E.M.N. Wielopolski, P.A. Hop, W.C.J. Osch-Gevers, L. van Pattynama, P.M.T. Keizer-Schrama, S.M.P.F.M. Helbing, W.A.
2008-07-01
Subclassification of small for gestational age children with persistent short stature: Growth patterns and response to GH treatment (Article)
Ester, W.A. Bannink, E.M.N. Dijk, M. van Willemsen, R.H. Kaay, D.C.M. van der Ridder, M.A.J. de Hokken-Koelega, A.C.S.
2008-01-01
Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age (Article)
Bannink, E.M.N. Doorn, J. van Mulder, P.G.H. Hokken-Koelega, A.C.S.
2007-08-01
Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls. (Article)
Dijk, M. van Bannink, E.M.N. Pareren, Y.K. van Hokken-Koelega, A.C.S. Mulder, P.G.H.
2007-01-01
SGA and Turner Syndrome: the impact of growth hormone treatment on physical and mental well-being (Doctoral Thesis)
Bannink, E.M.N.
2006-10-18